Oxidative Stress, Iron Metabolism, and Ferroptosis in Cancer and Neurodegeneration
This research community investigates the molecular mechanisms of reactive oxygen species, iron homeostasis, and ferroptosis to understand and treat cancer, neurodegenerative diseases, and metabolic disorders.
The work centers on the interplay between oxidative stress and iron metabolism, with frequent focus on ferroptosis as a form of regulated cell death. Recurring themes include the role of reactive oxygen species in signaling pathways, the impact of iron deficiency or overload on disease progression, and the development of targeted therapies for breast cancer, hepatocellular carcinoma, and colorectal cancer. The community also examines mitochondrial dysfunction, the tumor microenvironment, and the protective roles of antioxidants in conditions such as Alzheimer’s disease, Parkinson’s disease, and heart failure. These studies aim to elucidate how cellular redox balance and iron handling drive pathology and how these processes can be modulated for therapeutic benefit.
The largest share of the community's output is found in oxygen research, representing 6.4% of all oxygen-related studies, followed by iron at 4.5% and bromine at 2.5%. Oxygen also contributes the highest paper count within this group, with 37,616 papers.
The community comprises 112,634 papers, primarily published in the Journal of Biological Chemistry, Free Radical Biology and Medicine, and Antioxidants.
Recent work continues to explore the molecular mechanisms of oxidative stress and signaling pathways in disease contexts, including the role of reactive oxygen species in cancer therapy and the modulation of inflammatory responses in neurodegeneration.